- Home
- SPCX vs ABBV Comparison
SPCX vs ABBV Comparison
Compare SPCX & ABBV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SPCX | ABBV |
|---|---|---|
| Founded | N/A | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7T | 358.5B |
| IPO Year | 2026 | 2012 |
Fundamental Metrics
Financial Performance| Metric | SPCX | ABBV |
|---|---|---|
| Price | $137.96 | $265.76 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 18 |
| Target Price | N/A | ★ $253.71 |
| AVG Volume (30 Days) | ★ 103.3M | 3.7M |
| Earning Date | N/A | 04-29-2026 |
| Dividend Yield | N/A | ★ 3.39% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.42 |
| Revenue | N/A | ★ $61,160,000,000.00 |
| Revenue This Year | N/A | $11.87 |
| Revenue Next Year | N/A | $8.12 |
| P/E Ratio | ★ N/A | $109.32 |
| Revenue Growth | N/A | ★ 8.57 |
| 52 Week Low | $104.83 | $190.75 |
| 52 Week High | $176.75 | $267.47 |
Technical Indicators
Market Signals| Indicator | SPCX | ABBV |
|---|---|---|
| Relative Strength Index (RSI) | 51.75 | 64.27 |
| Support Level | $130.39 | $218.78 |
| Resistance Level | $149.80 | $267.47 |
| Average True Range (ATR) | 8.79 | 5.08 |
| MACD | 1.08 | 1.38 |
| Stochastic Oscillator | 69.76 | 94.43 |
Price Performance
Historical ComparisonAbout SPCX Space Exploration Technologies Corp.
Founded in 2002 and commonly known as SpaceX, the Space Exploration Technologies Corporation designs, manufactures, and operates a family of reusable rockets to launch various payloads into Earth orbit for government and commercial customers. Starting in 2019, the company began launching a constellation of its own communication satellites to provide mobile broadband and wireless services under the Starlink brand. In early 2026, the company acquired xAI from its founder, Elon Musk, which operates a large language artificial intelligence model named Grok, a gigawatt-scale data center called Colossus, and the social media network X.
About ABBV AbbVie Inc.
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.